iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Mankind Pharma Ltd Option Chain

Add as a Preferred Source on Google
2,579.5
(0.53%)
Jul 21, 2026|09:30:26 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--1,960₹0.35 0%6,500-13.33%
--2,000₹0.05 -87.5%7,7500%
--2,040₹0.1 -83.33%2500%
--2,080₹0.15 -62.5%15,7500%
00%₹331.9 0%2,100₹0.15 -80%2,250-65.38%
1,2500%₹459.1 0%2,120₹3 0%1,5000%
--2,140₹0.6 0%1,2500%
5000%₹419.2 0%2,160₹27.95 0%5000%
--2,180₹5.9 0%2,2500%
0-100%₹386.85 1.96%2,200₹0.25 -50%17,750-12.34%
2500%₹334.9 0%2,220₹8.45 0%2,7500%
--2,240₹8.3 0%5000%
5000%₹183.55 0%2,260₹0.5 -75%4,500-53.84%
1,2500%₹166.7 0%2,280₹1 5.26%4,250-34.61%
1,5000%₹211.35 0%2,300₹1.05 -30%23,000-1.07%
--2,320₹0.6 -65.71%10,250-10.86%
2500%₹270 0%2,340₹1.05 -48.78%4,000-20%
7500%₹137.95 -1.67%2,360₹1.2 -20%12,250-19.67%
5000%₹173.2 0%2,380₹1.5 -51.61%18,000-19.10%
7,2500%₹170 -0.11%2,400₹1.8 -53.24%41,000-9.39%
3,0000%₹113.2 0%2,420₹2.6 -43.47%16,75011.66%
2,0000%₹144.9 0%2,440₹3.1 -51.18%27,2500%
8,500-10.52%₹131.65 0.22%2,460₹4.6 -46.51%28,7501.76%
14,7500%₹114.3 0.88%2,480₹6.95 -35.94%32,75019.09%
66,500-18.40%₹91.55 -1.98%2,500₹10.3 -35.01%1,79,50011.31%
24,000-17.24%₹78.15 -3.15%2,520₹14.65 -28.18%37,000-16.85%
75,250-3.83%₹64.55 -3.58%2,540₹20.4 -22.28%84,2503.05%
1,07,000-1.38%₹50.95 -7.53%2,560₹28.8 -20.98%50,5002.02%
66,500-18.15%₹41.1 -9.67%2,580₹38.7 -13.9%22,000-11.11%
2,84,500-1.81%₹32.6 -11.05%2,600₹49.1 -10.56%85,0001.79%
36,0002.85%₹25.5 -12.96%2,620₹54.7 -19.38%11,0002.32%
80,750-5.55%₹19.75 -15.23%2,640₹164.95 4.66%76,2500%
22,75010.97%₹15.6 -14.28%2,660--
1,65,00043.79%₹12.25 -16.66%2,680₹185.55 0%2,5000%
1,16,2500.86%₹9.45 -14.47%2,700₹188 0%5000%
20,7502.46%₹6.9 -16.86%2,720--
15,250-1.61%₹5.6 -19.42%2,740--
41,0001.23%₹4.15 -9.78%2,760--
7,250-14.70%₹3 -25%2,780--
81,000-3.57%₹3.05 -3.17%2,800₹219.1 0%1,5000%
15,000-1.63%₹1.8 -12.19%2,840₹259.45 -12.93%00%
27,000-4.42%₹1.3 30%2,880--
18,500-1.33%₹0.8 -11.11%2,920₹388.5 0%7500%

Mankind Pharma: Related NEWS

Mankind Pharma Q1 Updates: Net profit down ~18%

The company also informed that its diluted earnings per share (EPS) slipped by 20.10% on a yearly basis to ₹10.60.

1 Aug 2025|01:41 PM
Read More
Top Stocks for Today - 01st August 2025

Here are some of the stocks that may see significant price movement today: Coal India, Mankind Pharma, Swiggy, etc.

1 Aug 2025|08:58 AM
Read More
Mankind Pharma posts mixed performance in Q4; stock slips ~4%

The business said that it logged a 10.70% year-on-year decline in its consolidated net profit at ₹420.80 Crore for Q4FY25.

22 May 2025|12:15 PM
Read More
Top Stocks for Today - 22nd May 2025

Here are some of the stocks that may see significant price movement today: NBCC, IndusInd Bank, Hindustan Zinc, etc.

22 May 2025|06:38 AM
Read More
Mankind Pharma Faces ₹183.11 Crore Tax Demand

The cumulative demand, including interest charges, is ₹183.11 crore.

30 Mar 2025|04:34 PM
Read More
Mankind Pharma Merges Three Subsidiaries

The merger took effect on March 29, 2025, after all necessary regulatory approvals were obtained.

30 Mar 2025|01:33 PM
Read More
Mankind Pharma Faces ₹111.68 Crore Tax Demand, Plans to Appeal

The tax adjustments pertain to Section 80IC/80IE, which involves deductions for businesses in special economic zones, and a disallowance of certain expenditures under Section 37(1) of the Act.

28 Feb 2025|11:13 PM
Read More
Top Stocks for Today - 24th January 2025

Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.

24 Jan 2025|07:50 AM
Read More
Mankind Pharma Q3 Profit Falls 16%, Revenue Jumps 24%

The company reported a good growth in EBITDA of 36.8% to ₹830 crore in the quarter against ₹606.5 crore in Q3 FY24.

23 Jan 2025|11:57 PM
Read More
Mankind Pharma Secures ₹5,000 Crore NCDs by Pledging 56.31% Stake in BSV

The NCDs issued are categorized, rated, secured, redeemable, and transferable, distributed across three series.

8 Jan 2025|04:01 PM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.